EVALUATION OF OCULAR SURFACE DISEASE IN PATIENTS AFTER TRABECULECTOMY: COMPARATIVE STUDY WITH AND WITHOUT INTRACAMERAL BEVACIZUMAB Sónia Parreira; Sandra.

Slides:



Advertisements
Similar presentations
World Cornea Congress VII Loteprednol Etabonate 0.5% Versus Cyclosporine 0.05% for Dry-Eye Syndrome After Bone Marrow Transplantation: A Prospective Randomized.
Advertisements

Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.
Delay in Symptom Resolution After Thermal Pulsation System Treatment for Meibomian Gland Dysfunction in Dry-Eye Disease Delay in Symptom Resolution After.
Non-Invasive Keratograph Tear Break-Up Time versus Invasive Fluorescein-Associated Tear Stability Test: Experimental Validation Study Nizar S Abdelfattah,
Yousef A Alghamdi, MD; Allison L McClellan, OD; Nabeel M Shalabi, MD Anat Galor, MD, MSPH Supported by the Department of Veterans Affairs, Veterans Health.
Young Joo Shin 1, Joo Hyun Kim 1, Jung Ha Kim 2, Woo Ho Nam 1, Kayoung Yi 1, Joon Young Hyon 3, 1 Department of Ophthalmology, Hallym University College.
W. B. Trattler; C. D. Reilly; D. F. Goldberg; P. A. Majmudar; J. A. Vukich; M. Packer; E. D. Donnenfeld.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Staining Patterns in Dry Eye Syndrome: Rose Bengal Versus Trypan Blue Rosane S. Castro (1) Lívia M. D. Freire (1), Renato Ambrosio Jr(2) 1-Ophthalmology.
Copyright restrictions may apply Sensitivity and Specificity of a Point-of-Care Matrix Metalloproteinase 9 Immunoassay for Diagnosing Inflammation Related.
5-year Results from a Prospective, Randomized Study of a Posterior Dynamic Stabilization System for the Lumbar Spine: DYNESYS Peter Gerszten 1, R. Davis.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore
Changes of Presenile Cataracts that had been Operated over 10 years in Korea Sung Kun Chung, M.D. ; Eun-Jung Jun, M.D. Hyun Seung Kim. Department of Ophthalmology.
Effects of Xalatan® (latanoprost) or Travatan® (travoprost) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients. M.B. McDonald1,
Bruce H. Koffler, MD University of Kentucky School of Medicine The author of this poster has received research funding and travel expense reimbursement.
Ocular Comfort Assessment of Bepotastine Besilate Ophthalmic Solution 1.5% in Multicenter Conjunctival Allergen Challenge Clinical Trial JA Gow 1, TT Macejko.
Autologous serum eye drops in severe post-LASIK dry eye.
Comparison of Bromfenac vs. Ketorolac During the Induction Phase of Treatment with Topical Cyclosporine for Dry Eye Patients Barry A. Schechter, MD Florida.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Evaluation of Systane® versus Placebo in Corneal Epithelial Healing Following Photorefractive Keratectomy (PRK) Lt Col Charles D. Reilly Major Vasudha.
The authors have no financial interest
FLUORESCEIN CLEARANCE TEST AS AN ADDITIONAL DIAGNOSTIC TOOL FOR DYSFUNCTIONAL TEAR SYNDROME Rodrigo de Nápole Azevêdo, MD Jamília Barros da Silva, MD Aline.
Peter A SimmonsA Cindy Carlisle-WilcoxA Perry S BinderB
Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.
Correlation of Conjunctival and Corneal Staining With Elevated Matrix Metalloproteinase-9 on the Ocular Surface of Dry-Eye Patients Authors: Allister Gibbons,
The Effect of Bimatoprost 0.03% vs Travoprost 0.004% in Patients on Latanoprost 0.005% Requiring Additional IOP Lowering Jeffrey A. Kammer, 1 Barry Katzman,
Efficacy and Safety of the Ex-PRESS Glaucoma Mini-Shunt with Intraoperative 5-Fluorouracil ASCRS 2009 – San Francisco A. Balashanmugam, MD, L. Farrokh-Siar,
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Comparison of Efficacy of 0.05% Cyclosporine Ophthalmic Emulsion
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
Descemet’s Stripping Endothelial Keratoplasty (DSEK) in patients with prior Trabeculectomy or Tube shunt surgery. Thadani S.M. Fynn-Thompson N. Authors.
Liquifaction Method and Extent of Posterior Capsule Opacification: Two-Year Follow-up Marie Kalfertova, Mariya Burova, Pavel Rozsival, Nada Jiraskova Nada.
THE EBK PROCEDURE FOR CORRECTION OF REFRACTIVE ERRORS
The Course of Dry Eye After Phacoemulsification Surgery Servet Cetinkaya 1, Emine Mestan 2, Nursen Oncel Acir 3, Yasemin Fatma Cetinkaya 4, Zeynep Dadaci.
Corneal CXL in Pediatric Patients with Progressive Keratoconus Stephanie Wise, Christian Diaz, Karolien Termote, Paul J. Dubord, Martin McCarthy, Sonia.
Nepafenac-Assisted Mydriasis During Cataract Surgery in a Rabbit Model Michael K. Yoon, MD and Stephen McLeod, MD UCSF Laser Vision Center, San Francisco,
Karin Spielmann & Lars Affentranger. Study aim To explore, if the sensitivity of the lid margins at the level of the lidwiper decreases with age.
Evaluation of combined middle and inferior meatal antrostomies for endonasal eradication of severe maxillary sinusitis Adel Said El-Antably.
Surgical Outcomes In Children With Primary Childhood Glaucoma
From: Lower Vitamin D Level and Distinct Tear Cytokine Profile Were Observed in Patients with Mild Dry Eye Signs but Exaggerated Symptoms Trans. Vis. Sci.
PROPHYLAXIS OF MACULAR EDEMA WITH PEROPERATIVE INTRAVITREAL BEVACIZUMAB IN PATIENTS WITH DIABETIC RETINOPATHY UNDERGOING PHACOEMULSIFICATION; A RANDOMIZED.
Department of Ophthalmology, University of Ulsan College of Medicine,
Finger prick Autologous Blood (FAB) as a novel approach to treatment of non-healing corneal epithelial defects and dry eyes James R Wawrzynski, Jonathan.
cross- sectional analyses of HEIJO-KYO Cohort
P-WT-325- Corneal Topography In Childhood Glaucoma Patients
Gerova V., V. Nakov, L. Tankova, P. Penchev, R. Nakov
Comparison of Endothelial Cell Loss After Phacoemulsification Performed by Third Year Residents and Anterior Segment Surgeons Alexandra Braunstein, MD.
The Authors have no financial interest
Volume 13, Issue 3, Pages (July 2015)
Late In-the-bag Intraocular Lens Dislocation:
Prevalence of Symptomatic Dry Eye Disease in an Urban Chinese Community: A Cross-sectional Population-based Study Venice SW LI, Sophie SL YEOW, Jeffrey.
B. Kozomara, E. Potkonjak, R. Lazic, N. Gabric
Oral Alcohol Administration Disturbs Tear Film and Ocular Surface
Copyright © 2002 American Medical Association. All rights reserved.
Conjunctival Goblet Cell Density Following Cataract Surgery With Diclofenac Versus Diclofenac and Rebamipide: A Randomized Trial  Kumiko Kato, Kensaku.
Treatment of hemorrhoids by selective embolization of the superior rectal arteries (SRA): initial experience. Primo, V. (1); Gregorio, A. (2); Andreo,
Preoperative Characteristics
A Randomised Cross Over Comparison of Trehalose/Hyaluronate Eye Drops and Standard Treatment: Patient Satisfaction in the Treatment of Dry Eye Syndrome.
Volume 119, Issue 10, Pages (October 2012)
Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD
A presentation to: Meeting name Date
Kyoto Prefectural University of Medicine
A Fresh Look at Dry Eye.
Conjunctival Impression Cytology in healthy volunteers
Reflux after Sleeve Gastrectomy and Hiatus Hernia Repair; a Study of Suture and Mesh repairs. Methods and Materials: 279 patients underwent (LSG) with.
Clinical study of open angle glaucoma surgery treatment trough deep slerectomy with T-Flux NV implant: three years follow-up Dr. Marco Rossi Dr Michele.
Sirel G. Güngör, MD Cem Küçükerdönmez, MD Yonca A. Akova, MD
Exploring Neurostimulation
A multicenter randomized controlled trial evaluating balneotherapy in patients with advanced chronic venous insufficiency  Patrick H. Carpentier, MD,
Presentation transcript:

EVALUATION OF OCULAR SURFACE DISEASE IN PATIENTS AFTER TRABECULECTOMY: COMPARATIVE STUDY WITH AND WITHOUT INTRACAMERAL BEVACIZUMAB Sónia Parreira; Sandra Barros; Diogo Lopes; Nadine Marques; Filipe Freitas; Paula Telles; Nuno Campos Hospital Garcia de Orta, Portugal INTRODUCTION FIGURE 1. Ocular Surface Disease Index questionnaire OCULAR SURFACE DISEASE (OSD) Multifactorial disease of the tears and ocular surface; Symptoms of discomfort, visual disturbance and tear film instability. TRABECULECTOMY First-line surgical treatment for glaucoma; Success rate has significantly improved with the ADJUNCTIVE ANTIMETABOLITES treatment, but some complications may compromise visual function postoperatively. PURPOSE The aim of this study was to compare clinical signs of OSD in patients who had undergone trabeculectomy with and without BEVACIZUMAB. FIGURE 2. Slitlamp micrograph of grading scale for corneal fluorescein staining. Grading scale of corneal fluorescein staining score ranged from 0 to 3 points Grade 0 – no staining Grade 1 – minimal staining Grade 2 – mild/moderate staining Grade 3 – severe staining MATERIALS AND METHODS Cross sectional, case comparison study: 21 patients (41 eyes); GROUP 1: 21 eyes underwent SIMPLE trabeculectomy; GROUP 2: 9 eyes underwent trabeculectomy with INTRACAMERAL BEVACIZUMAB; FELLOW EYES: 11 eyes that did not undergo surgery Patients completed the OCULAR SURFACE DISEASE INDEX (OSDI) questionnaire and total OSDI scores (0-100) were calculated; Evaluation of FLUORESCEIN corneal staining (score between 0-3) and a SCHIRMER tear test were executed for every patient. DISCUSSION AND CONCLUSIONS OSD is a clinical problem often overlooked in patients who undergo filtration surgery; The use of intracameral bevacizumab could be a SAFE and a possible adjunctive treatment without increasing complications when compared with simple trabeculectomy. Due to our small sample size, which limits the statistical comparison between the groups, further larger randomized trials are required to investigate the long term results. RESULTS Parameters of Group 1 and 2 were compared using the MANN- WHITNEY U test. Fellow eyes were compared with operated eyes using the WILCOXON test. There were NO SIGNIFICANT DIFFERENCES in the corneal staining score (P=0.422), Schirmer’s test results (P=0.326) and OSDI scores (P=0.053) between GROUPS 1 and 2. Corneal staining score was GREATER in OPERATED EYES than in non-operated eyes (1.27 vs 0.64; P=0.02). FELLOW EYES had SIGNIFICANTLY higher Schirmer’s results than eyes with trabeculectomy (22.00 vs 15.27; P=0.005). References 1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75–92. 2. Ammar DA, Kahook MY. The effects of combination glaucoma medications on ocular surface epithelial cells. Adv Ther. 2009;26(10):970–975. 3. Garcia-Feijoo J, Sampaolesi JR. A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Clin Ophthalmol. 2012; 6:441–6. 4. Walt, J. Ocular Surface Disease Index (OSDI) Administration and Scoring Manual. Irvine, CA: Allergan, Inc; 2004.